Clinical Trials

BlueWind Medical shared two-year data from the OASIS pivotal study of its implantable tibial neuromodulation (iTNM) system. Park City, Utah-based BlueWind said investigators presented...

Corvia Medical announced three-year positive results from its clinical trial of its Corvia Atrial Shunt. The REDUCE LAP-HF randomized trial evaluated the safety and efficacy...

Tioga Cardiovascular, a Shifamed portfolio company, announced the first-in-human implants for its Luna TMVR system. Luna, a 28 Fr. transcatheter mitral valve replacement (TMVR) system,...

Luna Diabetes launched a pivotal trial for Luna, its miniature automated insulin delivery system. The company describes the system — designed to transform nighttime...

Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset,...

SeaStar Medical has announced a significant milestone in its pivotal NEUTRALIZE-AKI trial with 51 subjects enrolled, surpassing the halfway point toward its target of...

Endospan completed enrolment for the primary arm of its TRIOMPHE FDA investigational device exemption (IDE) trial. TRIOMPHE evaluates the safety and efficacy of the...

Microbot Medical successfully completed enrolment and follow-up in its surgical robot clinical trial. The Braintree, Massachusetts–based company completed enrolment and follow-up for all patients...

Virginia-based Rivanna has initiated a feasibility study evaluating its artificial intelligence (AI) enabled Accuro XV musculoskeletal imaging system. The study will enrol 200 patients to...